Meanwhile, increased levels of human SAMD4A in myoblasts from DM1 patients restores the translation activity of CUGBP1, and thus inhibiting CUG-induced myopathy through physically interacting with CUGBP1. This evidence concerns the gene SAMD4A and myotonic dystrophy type 1.